Search - tctmd.com

Displaying 561 - 580 of 809

Sort: Relevancy | Date

Presentation ACC 2013

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Presenter: Vinod H. Thourani

March 11, 2013

Presentation ACC 2013

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

Presenter: Ajay J. Kirtane

March 11, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

Presentation ACC 2013

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

Presenter: Martin B. Leon

March 09, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Daily News

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Yael L. Maxwell

March 09, 2013

News Industry News

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

March 09, 2013

News Daily News

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

Caitlin E. Cox

March 03, 2013

News Industry News

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

February 27, 2013

News Daily News

TAVR Used for Severe Regurgitation Without Stenosis

February 20, 2013

News Daily News

La FA, Preexistente o No, Aumenta la Mortalidad en Pacientes sometidos a TAVR

Jason Kahn

February 11, 2013

News Daily News

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Jason Kahn

February 11, 2013

Presentation

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

Presenter: S. Stortecky

February 10, 2013

News Daily News

Studies Question Accuracy of Adenosine-Free Gauge of Stenosis Severity

Yael L. Maxwell

February 07, 2013

News Daily News

Estudios Cuestionan la Precisión de un Indicador sin Adenosina para Valorar la Severidad de la Estenosis

Yael L. Maxwell

February 07, 2013

News Industry News

St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial

February 03, 2013

Presentation TCT 2013

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Presenter: Stefan Stortecky, Peter Wenaweser, Thomas Pilgrim, Alexander Kadner, Lutz Buellesfeld, Christoph Huber, Ahmed Khattab, Stephan Windecker

January 31, 2013

Presentation TCT 2013

TransAortic Valve Implantation (TAVI) Normalises Subendocardial Function in Patients with Severe Aortic Stenosis

Presenter: Alison Duncan, Thomas Snow, Carlo Di Mario, Simon Davies, Neil Moat

January 31, 2013

Presentation TCT 2013

TAVR– 3 year results of transapical versus transfemoral approach in a real world population of 1000 patients with severe aortic stenosis

Presenter: G. Schymik, T. Herbinger, A. Wuerth, J.-S. Schymik, P. Bramlage, M. Heimeshoff, T. Sueselbeck, R. Kiefer, B.-D. Gonska, H. Posival, C. Schmitt, H. Schroefel

January 31, 2013

Advertisement

Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis

Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

TAVR Used for Severe Regurgitation Without Stenosis

La FA, Preexistente o No, Aumenta la Mortalidad en Pacientes sometidos a TAVR

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

Studies Question Accuracy of Adenosine-Free Gauge of Stenosis Severity

Estudios Cuestionan la Precisión de un Indicador sin Adenosina para Valorar la Severidad de la Estenosis

St. Jude Medical Announces First Implant Evaluating New Size of Portico Heart Valve in Ongoing European Clinical Trial

Gender Differences in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

TransAortic Valve Implantation (TAVI) Normalises Subendocardial Function in Patients with Severe Aortic Stenosis

TAVR– 3 year results of transapical versus transfemoral approach in a real world population of 1000 patients with severe aortic stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content